← All organizations
First clinical trial
Jan 1, 2000Last known activity
Dec 31, 2025
Timeline
2000s
- Jan 1, 2000
Curis— Founded
Drugs by trial phase (17 distinct, 19 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (13 own, 0 via acquisition)
Indications
Studied for
- Astrocytoma
- Brain Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Gastroesophageal Reflux
- Glioblastoma
- Glioma
- Head and Neck Neoplasms
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Liver Neoplasms
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Large B-Cell, Diffuse
- Medulloblastoma
- Myelodysplastic Syndromes
- Neoplasms
- Neuroblastoma
- Preleukemia
- Stomach Neoplasms
- Syndrome
- Triple Negative Breast Neoplasms
- Vesico-Ureteral Reflux
Recent trials (20)
- NCT07271667Lead sponsorPhase 2Dec 31, 2025
- NCT07107750CollaboratorPhase 1Oct 31, 2025
- NCT05187182CollaboratorPhase 1Nov 30, 2022
- NCT05178342CollaboratorPhase 2Jan 1, 2022
- NCT04475523Lead sponsorPhase 1Sep 22, 2020
- NCT04278768Lead sponsorPhase 1Feb 19, 2020
- NCT03893487CollaboratorEarly Phase 1Jul 31, 2019
- NCT03328078Lead sponsorPhase 1Dec 28, 2017
- NCT02909777CollaboratorPhase 1Oct 1, 2016
- NCT02812875Lead sponsorPhase 1May 1, 2016
- NCT02674750Lead sponsorPhase 2Jan 1, 2016
- NCT02307240Lead sponsorPhase 1Nov 1, 2014
- NCT01908413Lead sponsorPhase 1Jul 1, 2013
- NCT01742988Lead sponsorPhase 1Dec 1, 2012
- NCT01702285Lead sponsorPhase 1Sep 1, 2012
Details
- Founded
- Lexington, MA, US Jan 1, 2000
- Last known activity
- Dec 31, 2025